Emerging treatments
Melatonergic agents
A case report suggests that the melatonergic agents agomelatine and extended-release melatonin can aid in relieving sleep-related eating disorder.[93] Extended-release melatonin has been studied for the treatment of rapid eye movement sleep behavior disorder (RBD). While findings are conflicting, a “chronobiotic” protocol of low-dose extended-release melatonin given at the same time nightly improved RBD symptoms even several months after treatment discontinuation.[94]
Use of this content is subject to our disclaimer